alpha-D-Galp-(1->4)-beta-D-GlcpA-(1->4)-beta-D-Glcp-(1->4)-alpha-D-GlcpO[CH2]5NH2

Term ID

CHEBI:136740

Synonyms

5-aminopentyl alpha-D-galactopyranosyl-(1->4)-(beta-D-glucopyranosyluronic acid)-(1->4)-beta-D-glucopyranosyl-(1->4)-alpha-D-glucopyranoside
5-aminopentyl alpha-D-galactopyranosyl-(1->4)-beta-D-glucopyranuronosyl-(1->4)-beta-D-glucopyranosyl-(1->4)-alpha-D-glucopyranoside
5-aminopentyl alpha-D-galactosyl-(1->4)-beta-D-glucuronosyl-(1->4)-beta-D-glucosyl-(1->4)-alpha-D-glucoside
alpha-D-Gal-(1->4)-beta-D-GlcA-(1->4)-beta-D-Glc-(1->4)-alpha-D-GlcO[CH2]5NH2
Galalpha1-4GlcAbeta1-4Glcbeta1-4GlcalphaO[CH2]5NH2

Definition

An α-D-glucoside that is the 5-aminopentyl glycoside of a tetrasaccharide consisting of α-D-galactosyl, β-D-glucuronosyl, β-D-glucosyl and α-D-glucosyl residues linked sequentially (1→4).

References

patent:AU2015323651
patent:EP3000820
pubmed:28275152
reaxys:29433908

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-D-Galp-(1->4)-beta-D-GlcpA-(1->4)-beta-D-Glcp-(1->4)-alpha-D-GlcpO[CH2]5NH2

Phenotype where environments contain alpha-D-Galp-(1->4)-beta-D-GlcpA-(1->4)-beta-D-Glcp-(1->4)-alpha-D-GlcpO[CH2]5NH2

Phenotype modified by environments containing alpha-D-Galp-(1->4)-beta-D-GlcpA-(1->4)-beta-D-Glcp-(1->4)-alpha-D-GlcpO[CH2]5NH2

Phenotype affecting alpha-D-Galp-(1->4)-beta-D-GlcpA-(1->4)-beta-D-Glcp-(1->4)-alpha-D-GlcpO[CH2]5NH2

Human Disease Model